CNS Pharmaceuticals, Inc.
CNSP
$6.12
-$0.42-6.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.03% | 101.93% | -7.34% | 367.49% | 82.97% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 204.96% | -49.47% | 233.51% | -39.10% | -18.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -31.07% | 0.00% | -23.42% | 60.12% | -- |
| Total Current Assets | 3.03% | 58.48% | 17.20% | 244.37% | 33.98% |
|
|
|||||
| Total Current Assets | 3.03% | 58.48% | 17.20% | 244.37% | 33.98% |
| Net Property, Plant & Equipment | -22.45% | -18.33% | 114.29% | -22.22% | -16.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,535.27% | -38.46% | 97.83% | -94.26% | 479.20% |
| Total Assets | 5.52% | 58.02% | 17.43% | 200.06% | 48.67% |
|
|
|||||
| Total Accounts Payable | -50.90% | 16.84% | -45.39% | -39.37% | 12.95% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -42.19% | -35.39% | 945.19% | -74.68% | -42.19% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -50.24% | 10.10% | -37.78% | -40.01% | 11.02% |
|
|
|||||
| Total Current Liabilities | -50.24% | 10.10% | -37.78% | -40.01% | 11.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -42.19% | -35.39% | 945.19% | -74.68% | -42.19% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -50.24% | 10.10% | -37.78% | -40.01% | 11.02% |
|
|
|||||
| Common Stock & APIC | 4.54% | 10.04% | 7.09% | 18.57% | 3.88% |
| Retained Earnings | -2.68% | -5.09% | -3.91% | -7.41% | -3.46% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 19.64% | 77.61% | 84.25% | 178.08% | 3.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.64% | 77.61% | 84.25% | 178.08% | 3.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.64% | 77.61% | 84.25% | 178.08% | 3.09% |
|
|
|||||